![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
. | ![]() |
. |
![]() by AFP Staff Writers Baghdad (AFP) Sept 12, 2021
Iraq on Sunday received a donation of more than 100,000 AstraZeneca doses against Covid-19 from Italy via vaccine-sharing facility Covax, the UN children's agency UNICEF said. More than four million people in Iraq, or around 10 percent of its 40 million inhabitants, have received at least one coronavirus vaccine jab, according to the health ministry. Healthcare workers say they are battling not just the coronavirus but also widespread scepticism over vaccines, as a result of misinformation and public mistrust in the state. Iraq on Sunday received "100,800 (doses) of the AstraZeneca vaccine... the first delivery from a pledge of 15 million doses to be donated to Covax by Italy", according to a statement from UNICEF, which works jointly with the World Health Organization (WHO). Covax is backed by WHO, the Gavi vaccine alliance and the Coalition for Epidemic Preparedness Innovations (CEPI), and it aims to ensure equitable distribution of Covid-19 vaccines, particularly to low-income countries. It is Iraq's third vaccine delivery under the Covax program. Iraq's public health system, already worn down by decades of war, under-investment and corruption, has struggled to cope with the pandemic. "In WHO, we believe that we are only safe when we all are safe, and we will control this pandemic only when all people eligible for the vaccine have been vaccinated," said Ahmed Zouiten, WHO's Iraq representative. Iraq began its vaccination campaign in March, using the Pfizer-BioNTech, AstraZeneca and Sinopharm jabs. The country has officially registered more than 1.9 million coronavirus cases, and almost 21,500 deaths since the start of its outbreak. Measures such as social distancing and mask-wearing are widely ignored. Two deadly fires this year in Covid-19 hospital units, one killing more than 80 people in Baghdad in April and another costing at least 60 lives in July in Nasiriyah, southern Iraq, have sparked outrage among the population. ak-tgg/gde/lg/hc
![]() ![]() Sinovac opens global pediatric vaccine trial in S.Africa Pretoria (AFP) Sept 10, 2021 South Africa on Friday launched the main phase of a global Covid vaccine study on children and teenagers led by Chinese maker Sinovac Biotech, with the first two participants jabbed in Pretoria. The study is testing the efficacy of Sinovac's two-dose CoronaVac on 14,000 children aged between six months and 17 years in Chile, Kenya, Malaysia, the Philippines, and South Africa. CoronaVac is approved for use among adults in over 50 countries. China recently cleared it for use in minors, where it ha ... read more
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |